دورية أكاديمية
Indigo Naturalis in Inflammatory Bowel Disease: mechanisms of action and insights from clinical trials
| العنوان: | Indigo Naturalis in Inflammatory Bowel Disease: mechanisms of action and insights from clinical trials |
|---|---|
| المؤلفون: | Hyeonjin Kim, Soohyun Jeong, Sung Wook Kim, Hyung-Jin Kim, Dae Yong Kim, Tae Han Yook, Gabsik Yang |
| المصدر: | Journal of Pharmacopuncture, Vol 27, Iss 2, Pp 59-69 (2024) |
| بيانات النشر: | Korean Pharmacopuncture Institute, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Medicine LCC:Miscellaneous systems and treatments LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | anti-inflammatory, indigo naturalis, inflammatory bowel disease, intestinal microbiota, immunomodulation, random clinical trial, Medicine, Miscellaneous systems and treatments, RZ409.7-999, Therapeutics. Pharmacology, RM1-950 |
| الوصف: | This study investigates the therapeutic potential of Indigo Naturalis (IN) in treating a Inflammatory Bowel Disease (IBD). The objective is to comprehensively examine the effects and pharmacological mechanisms of IN on IBD, assessing its potential as an novel treatment for IBD. Analysis of 11 selected papers is conducted to understand the effects of IN, focusing on compounds like indirubin, isatin, indigo, and tryptanthrin. This study evaluates their impact on Disease Activity Index (DAI) score, colon length, mucosal damage, and macrophage infiltration in Dextran Sulfate Sodium (DSS)-induced colitis mice. Additionally, It investigate into the anti-inflammatory mechanisms, including Aryl hydrocarbon Receptor (AhR) pathway activation, Nuclear Factor kappa B (NF-κB)/nod-like receptor family pyrin domain containing 3 (NLRP3)/Interleukin 1 beta (IL-1β) inhibition, and modulation of Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MYD88)/NF-κB and Mitogen Activated Protein Kinase (MAPK) pathways. Immunomodulatory effects on T helper 17 (Th17)/regulatory T cell (Treg cell) balance and Glycogen synthase kinase-3 beta (GSK3-β) expression are also explored. Furthermore, the study addresses the role of IN in restoring intestinal microbiota diversity, reducing pathogenic bacteria, and increasing beneficial bacteria. The findings reveal that IN, particularly indirubin and indigo, demonstrates significant improvements in DAI score, colon length, mucosal damage, and macrophage infiltration in DSS-induced colitis mice. The anti-inflammatory effects are attributed to the activation of the AhR pathway, inhibition of inflammatory pathways, and modulation of immune responses. These results exhibit the potential of IN in IBD treatment. Notably, the restoration of intestinal microbiota diversity and balance further supports its efficacy. IN emerges as a promising and effective treatment for IBD, demonstrating anti-inflammatory effects and positive outcomes in preclinical studies. However, potential side effects necessitate further investigation for safe therapeutic development. The study underscores the need for future research to explore a broader range of active ingredients in IN to enhance therapeutic efficacy and safety. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English Korean |
| تدمد: | 2093-6966 |
| Relation: | http://www.journal-jop.org/journal/view.html?doi=10.3831/KPI.2024.27.2.59; https://doaj.org/toc/2093-6966 |
| DOI: | 10.3831/KPI.2024.27.2.59 |
| URL الوصول: | https://doaj.org/article/388b476ce7a24cdca066c533f48c55d8 |
| رقم الأكسشن: | edsdoj.388b476ce7a24cdca066c533f48c55d8 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 20936966 |
|---|---|
| DOI: | 10.3831/KPI.2024.27.2.59 |